Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Americold Realty Trust | COLD | Sep 27, 2024 | 28.60 | -0.10 |
Ameriprise Financial | AMP | Sep 27, 2024 | 468.62 | +0.24 |
Ameris Bancorp | ABCB | Sep 27, 2024 | 61.32 | -0.23 |
Amerisafe | AMSF | Sep 27, 2024 | 48.32 | -0.33 |
AmeriServ Financial | ASRV | Sep 27, 2024 | 2.65 | -1.85 |
Ames National | ATLO | Sep 27, 2024 | 18.50 | +1.59 |
Amesite | AMST | Sep 27, 2024 | 2.51 | -3.49 |
Ametek | AME | Sep 27, 2024 | 172.07 | +0.06 |
Amgen | AMGN | Sep 27, 2024 | 322.67 | +1.12 |
Amicus Therapeutics | FOLD | Sep 27, 2024 | 10.71 | -0.09 |
Amkor Technology | AMKR | Sep 27, 2024 | 30.89 | -3.20 |
AMMO | POWW | Sep 27, 2024 | 1.44 | -0.69 |
AMMO A Pref | POWWP | Sep 27, 2024 | 21.99 | -17.18 |
AMN Healthcare Services | AMN | Sep 27, 2024 | 42.57 | -0.14 |
Amneal Pharmaceuticals A | AMRX | Sep 27, 2024 | 8.19 | -1.92 |
Ampco-Pittsburgh | AP | Sep 27, 2024 | 2.04 | -1.45 |
Amphastar Pharmaceuticals | AMPH | Sep 27, 2024 | 48.02 | +0.29 |
Amphenol | APH | Sep 27, 2024 | 65.02 | -1.07 |
Amplify Energy | AMPY | Sep 27, 2024 | 6.41 | +2.56 |
Amplify Online Retail ETF | IBUY | Sep 27, 2024 | 60.97 | +0.48 |
Amplify Transformational Data Sharing ETF | BLOK | Sep 27, 2024 | 38.30 | +0.37 |
Amplitech Group | AMPG | Sep 27, 2024 | 0.84 | +2.33 |
Amplitude A | AMPL | Sep 27, 2024 | 8.95 | +1.36 |
Amprius Technologies | AMPX | Sep 27, 2024 | 1.11 | +19.21 |
AMREP | AXR | Sep 27, 2024 | 29.58 | +0.65 |
AMTD Digital ADR | HKD | Sep 27, 2024 | 3.57 | +8.51 |
AMTD Idea Group ADR | AMTD | Sep 27, 2024 | 1.40 | +6.06 |
Amtech Systems | ASYS | Sep 27, 2024 | 6.09 | -0.65 |
Amylyx Pharmaceuticals | AMLX | Sep 27, 2024 | 3.08 | -3.75 |
AN2 Therapeutics | ANTX | Sep 27, 2024 | 1.06 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.